UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 105

Sortiert nach

Multiplatform-based molecular subtypes of non-small-cell lung cancer

Oncogene, 2017-03, Vol.36 (10), p.1384-1393

2017

Link zum Volltext

Verfügbarkeit prüfen

Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition

Oncogene, 2011-10, Vol.30 (40), p.4163-4174

2011

Link zum Volltext

Verfügbarkeit prüfen

Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression

Oncogene, 2011-03, Vol.30 (11), p.1351-1359

2011

Link zum Volltext

Verfügbarkeit prüfen

Vimentin is a novel AKT1 target mediating motility and invasion

Oncogene, 2011-01, Vol.30 (4), p.457-470

2011

Link zum Volltext

Verfügbarkeit prüfen

Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells

Oncogene, 2007-03, Vol.26 (13), p.1840-1851

2007

Link zum Volltext

Verfügbarkeit prüfen

Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling

Oncogene, 2011-11, Vol.30 (45), p.4567-4577

2011

Link zum Volltext

Verfügbarkeit prüfen

Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer

Oncogene, 2016-02, Vol.35 (6), p.691-701

2016

Link zum Volltext

Verfügbarkeit prüfen

Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer

Oncogene, 2014-05, Vol.33 (22), p.2846-2856

2014

Link zum Volltext

Verfügbarkeit prüfen

Coordinate phosphorylation of multiple residues on single AKT1 and AKT2 molecules

Oncogene, 2014-06, Vol.33 (26), p.3463-3472

2014

Link zum Volltext

Verfügbarkeit prüfen

Correction: Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer

Oncogene, 2019-05, Vol.38 (22), p.4427-4428

2019

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias

Leukemia, 2004-02, Vol.18 (2), p.267-275

2004

Link zum Volltext

Verfügbarkeit prüfen

Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer

Oncogene, 2010-06, Vol.29 (23), p.3374-3385

2010

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death

Oncogene, 2011-03, Vol.30 (9), p.1127-1134

2011

Link zum Volltext

Verfügbarkeit prüfen

PIK3CA is implicated as an oncogene in ovarian cancer

Nature genetics, 1999-01, Vol.21 (1), p.99-102

1999

Link zum Volltext

Verfügbarkeit prüfen

Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium

Oncogene, 2011-02, Vol.30 (6), p.724-736

2011

Link zum Volltext

Verfügbarkeit prüfen

Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway

Oncogene, 1999-11, Vol.18 (48), p.6635-6640

1999

Link zum Volltext

Verfügbarkeit prüfen

Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p

Oncogene, 2017-03, Vol.36 (10), p.1339-1350

2017

Link zum Volltext

Verfügbarkeit prüfen

The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells

Oncogene, 1999-11, Vol.18 (50), p.7034-7045

1999

Link zum Volltext

Verfügbarkeit prüfen

Site-specific activation of AKT protects cells from death induced by glucose deprivation

Oncogene, 2014-02, Vol.33 (6), p.745-755

2014

Link zum Volltext

Verfügbarkeit prüfen

hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness

Oncogene, 2015-06, Vol.34 (26), p.3402-3412

2015

Link zum Volltext

Verfügbarkeit prüfen

Neomorphic mutations create therapeutic challenges in cancer

Oncogene, 2017-03, Vol.36 (12), p.1607-1618

2017

Link zum Volltext

Verfügbarkeit prüfen

Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions

Oncogene, 2007-04, Vol.26 (18), p.2574-2584

2007

Link zum Volltext

Verfügbarkeit prüfen

Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer

Oncogene, 2016-04, Vol.35 (17), p.2186-2196

2016

Link zum Volltext

Verfügbarkeit prüfen

MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition

Oncogene, 2012-10, Vol.31 (41), p.4434-4446

2012

Link zum Volltext

Verfügbarkeit prüfen

The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers

Nature medicine, 2004-11, Vol.10 (11), p.1251-1256

2004

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 105

Suche als RSS-Feed

Aktive Filter

KollektionNexis

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(105)
Mit Volltextzugriff
(83)

Publikationsform

Artikel
(105)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(87)
Humans
(80)
Life Sciences & Biomedicine
(69)
Oncology
(46)
Genetics & Heredity
(45)
Biochemistry & Molecular Biology
(39)
Cell Biology
(38)
Female
(36)
Biological And Medical Sciences
(35)
Genetic Aspects
(31)
Fundamental And Applied Biological Sciences. Psychology
(27)
Genetics
(25)
Animals
(24)
Tumors
(24)
Health Aspects
(23)
Mutation
(22)
Gene Expression
(21)
Kinases
(21)
Molecular And Cellular Biology
(21)
Breast Cancer
(19)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Multiplatform-based molecular subtypes of non-small-cell lung cancer

Phosphoproteomic mass spectrometry profiling links Src family kinases to escape from HER2 tyrosine kinase inhibition

Lysophosphatidic acid augments human hepatocellular carcinoma cell invasion through LPA1 receptor and MMP-9 expression

Vimentin is a novel AKT1 target mediating motility and invasion

Silencing mammalian target of rapamycin signaling by small interfering RNA enhances rapamycin-induced autophagy in malignant glioma cells

Kinome siRNA-phosphoproteomic screen identifies networks regulating AKT signaling

Functional proteomics identifies miRNAs to target a p27/Myc/phospho-Rb signature in breast and ovarian cancer

Self-reinforcing loop of amphiregulin and Y-box binding protein-1 contributes to poor outcomes in ovarian cancer

Coordinate phosphorylation of multiple residues on single AKT1 and AKT2 molecules

Correction: Musashi RNA-binding protein 2 regulates estrogen receptor 1 function in breast cancer

Inhibition of phosphatidylinositol 3-kinase dephosphorylates BAD and promotes apoptosis in myeloid leukemias

Integrin-linked kinase has a critical role in ErbB2 mammary tumor progression: implications for human breast cancer

Inhibition of c-Met downregulates TIGAR expression and reduces NADPH production leading to cell death

PIK3CA is implicated as an oncogene in ovarian cancer

Int6 regulates both proteasomal degradation and translation initiation and is critical for proper formation of acini by human mammary epithelium

Regulation of BAD phosphorylation at serine 112 by the Ras-mitogen-activated protein kinase pathway

Targeting KRas-dependent tumour growth, circulating tumour cells and metastasis in vivo by clinically significant miR-193a-3p

The PTEN/MMAC1/TEP tumor suppressor gene decreases cell growth and induces apoptosis and anoikis in breast cancer cells

Site-specific activation of AKT protects cells from death induced by glucose deprivation

hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness

Neomorphic mutations create therapeutic challenges in cancer

Identification of a novel splice variant of AML1b in ovarian cancer patients conferring loss of wild-type tumor suppressive functions

Grb2 depletion under non-stimulated conditions inhibits PTEN, promotes Akt-induced tumor formation and contributes to poor prognosis in ovarian cancer

MKNK1 is a YB-1 target gene responsible for imparting trastuzumab resistance and can be blocked by RSK inhibition

The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers

Aktive Filter

Suchergebnisse filtern